SightfileU.S. market data from official filings

Companies › CYTK

CYTOKINETICS INC (CYTK)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001061983 · EDGAR filings · Updated 2026-07-27

CYTOKINETICS INC (CYTK) has reported institutional ownership of 117.4%, with 438 institutional managers holding positions valued at $9.62B per the latest 13F reporting period.

Institutional ownership
117.4%
Institutional managers
438
Reported 13F value
$9.62B
Insider activity
171 trans.
−$25.1M net selling

Filings this week (2)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CYTOKINETICS INC has 438 institutional holders and institutional ownership of 117.4%.

Insider activity

Insiders reported 171 transactions (0 buys, 76 sells) across 15 reporting insiders, with a net reported value of −$25.1M.

Related companies

BEONE MEDICINES LTD (ONC) · REVVITY INC (RVTY) · SANOFI SA (SNY) · DAVITA INC (DVA) · MASIMO CORP (MASI) · VAXCYTE INC (PCVX)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-27.